Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 1/20 | 0.59 |
| ▸ | ACLY | P53396 | 10/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15157614 | 0.86 | BCL2 (0.80) | BCL2ACLYSLC2A1MEN1KMT2A | |
| SCHEMBL184447 | 0.81 | BCL2 (0.61) | BCL2ACLYMEN1KMT2APOLB | |
| SCHEMBL184913 | 0.79 | BCL2 (0.80) | BCL2ACLYMEN1KMT2APOLB | |
| SCHEMBL185121 | 0.78 | BCL2 (0.85) | BCL2ACLYSLC2A1EGFRERBB2 | |
| SCHEMBL184499 | 0.77 | ACLY (0.78) | BCL2ACLY | |
| SCHEMBL184600 | 0.76 | BCL2 (1.00) | BCL2ACLYEGFRERBB2LMNA | |
| SCHEMBL185430 | 0.74 | BCL2 (0.66) | BCL2ACLYEGFRERBB2LMNA | |
| SCHEMBL184568 | 0.73 | ACLY (0.69) | BCL2ACLY | |
| SCHEMBL184838 | 0.73 | BCL2 (0.81) | BCL2ACLYEGFRERBB2ALDH1A1 | |
| SCHEMBL185275 | 0.72 | ACLY (0.70) | BCL2ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297103-B1 | HYDROXYPHENYLSULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2012-01-04 | — | — | EP | disclosed |